![]() ![]() With the news, Portola Pharmaceuticals’ drug becomes the first and only antidote approved for the indication. Food and Drug Administration (FDA) has approved coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for patients treated with rivaoxaban and apixaban, when reversal of anticoagulation is necessary due to fatal or uncontrolled bleeding.
0 Comments
Leave a Reply. |